M34.83 identifies systemic sclerosis (scleroderma) complicated by polyneuropathy — diffuse peripheral nerve damage occurring as a direct manifestation of the underlying connective tissue disease.

Documentation tips

What should appear in the chart to support M34.83.

Source · Editorial brief grounded in 5 cited references ↓

• Provider must explicitly link the polyneuropathy to systemic sclerosis — document 'polyneuropathy due to systemic sclerosis' or equivalent; a standalone neuropathy diagnosis without that link does not support M34.83.
• Record the subtype of systemic sclerosis (diffuse vs. limited/CREST) even though M34.83 does not differentiate by subtype — this supports the full clinical picture for audit purposes.
• Document all organ manifestations separately (lung involvement, myopathy, polyneuropathy) so each can be coded; co-reporting M34.81, M34.82, and M34.83 together is appropriate when all are present and documented.
• Include nerve conduction study or EMG results that confirm polyneuropathy pattern, as these substantiate medical necessity for neurology or rheumatology workup tied to this code.
• Note any prior workup ruling out competing etiologies for neuropathy (e.g., diabetes, B12 deficiency, alcohol) to support attribution to scleroderma in the medical record.

Related CPT procedures

Procedure codes commonly billed with M34.83. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M34.83 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

• Coding M34.83 when the polyneuropathy has a separate documented cause (e.g., diabetic neuropathy) rather than being explicitly attributed to systemic sclerosis — these are not interchangeable; use the etiology-specific code instead.
• Using M34.9 (unspecified systemic sclerosis) out of habit when M34.83 is clearly supported by documentation — M34.9 is a specificity downgrade and can trigger an audit flag.
• Reporting L94.0 (localized scleroderma/morphea) alongside M34.83 — the Excludes1 note at the M34 category level prohibits coding both simultaneously.
• Failing to code additional M34.8x manifestation codes (e.g., M34.81 for lung involvement) when multiple organ complications are documented — each billable manifestation should be captured.

Clinical context

Source · Editorial summary grounded in 5 cited references ↓

Sibling codes

Other billable codes under M34.8 (laterality / anatomic variants).